Death-related distress in adult primary brain tumor patients.
death anxiety
death-related distress
neuro-oncology
primary brain tumor
quality of life
Journal
Neuro-oncology practice
ISSN: 2054-2577
Titre abrégé: Neurooncol Pract
Pays: England
ID NLM: 101640528
Informations de publication
Date de publication:
Oct 2020
Oct 2020
Historique:
entrez:
5
10
2020
pubmed:
6
10
2020
medline:
6
10
2020
Statut:
epublish
Résumé
A diagnosis of cancer may increase mortality salience and provoke death-related distress. Primary brain tumor (PBT) patients may be at particular risk for such distress given the certainty of tumor progression, lack of curative treatments, and poor survival rates. This study is the first to examine the prevalence of death-related distress and its correlates in PBT patients. Adult PBT patients (N = 105) enrolled in this cross-sectional study and completed the Death Distress Scale (subscales: Death Depression, Death Anxiety, Death Obsession), Generalized Anxiety Disorder-7, and Patient Health Questionnaire-9. Prevalence and predictors of death-related distress, and the relationships of demographic variables to clusters of distress, were explored. The majority of PBT patients endorsed clinically significant death-related distress in at least one domain. Death anxiety was endorsed by 81%, death depression by 12.5%, and death obsession by 10.5%. Generalized anxiety was the only factor associated with global death-related distress. Cluster analysis yielded 4 profiles: global distress, emotional distress, resilience, and existential distress. Participants in the resilience cluster were significantly further out from diagnosis than those in the existential distress cluster. There were no differences in cluster membership based on age, sex, or tumor grade. PBT patients appear to have a high prevalence of death-related distress, particularly death anxiety. Further, 4 distinct profiles of distress were identified, supporting the need for tailored approaches to addressing death-related distress. A shift in clusters of distress based on time since diagnosis also suggest the need for future longitudinal assessment.
Sections du résumé
BACKGROUND
BACKGROUND
A diagnosis of cancer may increase mortality salience and provoke death-related distress. Primary brain tumor (PBT) patients may be at particular risk for such distress given the certainty of tumor progression, lack of curative treatments, and poor survival rates. This study is the first to examine the prevalence of death-related distress and its correlates in PBT patients.
METHODS
METHODS
Adult PBT patients (N = 105) enrolled in this cross-sectional study and completed the Death Distress Scale (subscales: Death Depression, Death Anxiety, Death Obsession), Generalized Anxiety Disorder-7, and Patient Health Questionnaire-9. Prevalence and predictors of death-related distress, and the relationships of demographic variables to clusters of distress, were explored.
RESULTS
RESULTS
The majority of PBT patients endorsed clinically significant death-related distress in at least one domain. Death anxiety was endorsed by 81%, death depression by 12.5%, and death obsession by 10.5%. Generalized anxiety was the only factor associated with global death-related distress. Cluster analysis yielded 4 profiles: global distress, emotional distress, resilience, and existential distress. Participants in the resilience cluster were significantly further out from diagnosis than those in the existential distress cluster. There were no differences in cluster membership based on age, sex, or tumor grade.
CONCLUSIONS
CONCLUSIONS
PBT patients appear to have a high prevalence of death-related distress, particularly death anxiety. Further, 4 distinct profiles of distress were identified, supporting the need for tailored approaches to addressing death-related distress. A shift in clusters of distress based on time since diagnosis also suggest the need for future longitudinal assessment.
Identifiants
pubmed: 33014390
doi: 10.1093/nop/npaa015
pii: npaa015
pmc: PMC7516120
doi:
Types de publication
Journal Article
Langues
eng
Pagination
498-506Informations de copyright
© The Author(s) 2020. Published by Oxford University Press on behalf of the Society for Neuro-Oncology and the European Association of Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Références
J Pain Symptom Manage. 1996 Nov;12(5):300-7
pubmed: 8942125
Death Stud. 2004 May;28(4):309-40
pubmed: 15129688
Death Stud. 2019;43(1):9-19
pubmed: 29393825
Midwifery. 2015 Jan;31(1):184-90
pubmed: 25217107
Cancer. 2011 Jan 1;117(1):218-27
pubmed: 20737537
J Clin Psychol Med Settings. 2019 Dec 17;:
pubmed: 31848927
J Clin Oncol. 2014 May 20;32(15):1605-19
pubmed: 24733793
BMJ Support Palliat Care. 2015 Dec;5(4):373-80
pubmed: 24644177
J Clin Oncol. 2002 Apr 1;20(7):1907-17
pubmed: 11919251
Psychooncology. 2015 Jan;24(1):70-9
pubmed: 24962968
J Pers Assess. 1987 Fall;51(3):451-61
pubmed: 3656059
Clin Psychol Rev. 2014 Nov;34(7):580-93
pubmed: 25306232
Cancer. 2017 Apr 1;123(7):1084-1085
pubmed: 28323343
Palliat Med. 2000 Nov;14(6):499-507
pubmed: 11219880
J Pediatr Hematol Oncol. 2011 Oct;33 Suppl 2:S140-5
pubmed: 21952572
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Support Care Cancer. 2018 Aug;26(8):2571-2579
pubmed: 29450638
J Gen Psychol. 1970 Apr;82(2d Half):165-77
pubmed: 4394812
J Clin Oncol. 2007 Oct 20;25(30):4829-34
pubmed: 17947732
J Pers Soc Psychol. 2002 Nov;83(5):1150-64
pubmed: 12416919
J Clin Psychol Med Settings. 2017 Mar;24(1):47-58
pubmed: 28124180
Palliat Support Care. 2009 Sep;7(3):299-306
pubmed: 19788771
Egypt Heart J. 2018 Sep;70(3):143-147
pubmed: 30190638
J Pain Symptom Manage. 2015 Jan;49(1):126-34
pubmed: 24878066
Eur J Cancer Care (Engl). 2010 Jul;19(4):522-9
pubmed: 20030697
Palliat Med. 2002 Jul;16(4):331-8
pubmed: 12132546
J Psychosom Res. 2018 Aug;111:120-126
pubmed: 29935744
Omega (Westport). 2011-2012;64(2):171-84
pubmed: 22375351
J Psychosoc Oncol. 2012;30(3):347-58
pubmed: 22571248
Lancet. 2000 Oct 14;356(9238):1326-7
pubmed: 11073026
J Clin Psychol. 1990 Nov;46(6):834-9
pubmed: 2286679
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941